Session » Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Imaging
- 2:00PM-3:30PM
-
Abstract Number: 1645
Aortic Dilatation and PET/CT Vascular Activity at Diagnosis and 5 Years in an Inception Giant Cell Arteritis (GCA) Cohort
- 2:00PM-3:30PM
-
Abstract Number: 1647
Association Between Vascular FDG Uptake at Diagnosis and Evolution in Aortic Dimensions in Giant Cell Arteritis: A Prospective Study
- 2:00PM-3:30PM
-
Abstract Number: 1648
EULAR Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice: 2023 Update
- 2:00PM-3:30PM
-
Abstract Number: 1649
Follow-up Ultrasound Examination in Patients with Newly Diagnosed Giant Cell Arteritis
- 2:00PM-3:30PM
-
Abstract Number: 1650
Optic Nerve Sheath Measurement as a Disease Activity Biomarker in Giant Cell Arteritis
- 2:00PM-3:30PM
-
Abstract Number: 1646
The Real-World Experience of Combined Cranial and Large Vessel FDG-PET/CT in the Investigation of Giant Cell Arteritis